Price Alert

Lifecore Biomedical Inc. (LFCR)

NASDAQ: LFCR · Real-Time Price · USD

7.37

-0.05 (-0.67%)

At close: Aug 15, 2025, 3:59 PM

7.37

0.07%

After-hours: Aug 15, 2025, 04:04 PM EDT

Lifecore Biomedical Statistics

Share Statistics

Lifecore Biomedical has 37.03M shares outstanding. The number of shares has increased by 19.96% in one year.

Shares Outstanding	37.03M
Shares Change (YoY)	19.96%
Shares Change (QoQ)	0%
Owned by Institutions (%)	66.21%
Shares Floating	34.17M
Failed to Deliver (FTD) Shares	3,695
FTD / Avg. Volume	1.85%

Short Selling Information

The latest short interest is 2.45M, so 6.62% of the outstanding shares have been sold short.

Short Interest	2.45M
Short % of Shares Out	6.62%
Short % of Float	10.72%
Short Ratio (days to cover)	15.19

Valuation Ratios

The PE ratio is 14.26 and the forward PE ratio is -10.41. Lifecore Biomedical's PEG ratio is -0.13.

PE Ratio	14.26
Forward PE	-10.41
PS Ratio	1.34
Forward PS	2
PB Ratio	3.18
P/FCF Ratio	-9.44
PEG Ratio	-0.13

Financial Ratio History

Enterprise Valuation

Lifecore Biomedical has an Enterprise Value (EV) of 293.16M.

EV / Sales	2.29
EV / EBITDA	8.23
EV / EBIT	-1350.98
EV / FCF	-16.16

Financial Position

The company has a current ratio of 2.08, with a Debt / Equity ratio of 2.42.

Current Ratio	2.08
Quick Ratio	1.06
Debt / Equity	2.42
Debt / EBITDA	3.66
Debt / FCF	-7.19
Interest Coverage	-0.49

Financial Efficiency

Return on Equity is 22.29% and Return on Invested Capital is -3.94%.

Return on Equity	22.29%
Return on Assets	4.39%
Return on Invested Capital	-3.94%
Revenue Per Employee	$244.77K
Profits Per Employee	$22.93K
Employee Count	524
Asset Turnover	0.47
Inventory Turnover	2.16

Taxes

Income Tax	183K
Effective Tax Rate	1.92%

Stock Price Statistics

The stock price has increased by 32.97% in the last 52 weeks. The beta is 0.65, so Lifecore Biomedical's price volatility has been higher than the market average.

Beta	0.65
52-Week Price Change	32.97%
50-Day Moving Average	7.44
200-Day Moving Average	6.73
Relative Strength Index (RSI)	45.36
Average Volume (20 Days)	199,629

Income Statement

In the last 12 months, Lifecore Biomedical had revenue of 128.26M and earned 12.01M in profits. Earnings per share was 0.39.

Revenue	128.26M
Gross Profit	41.85M
Operating Income	-8.84M
Net Income	12.01M
EBITDA	35.6M
EBIT	27.6M
Earnings Per Share (EPS)	0.39

Full Income Statement

Balance Sheet

The company has 8.46M in cash and 130.36M in debt, giving a net cash position of -121.9M.

Cash & Cash Equivalents	8.46M
Total Debt	130.36M
Net Cash	-121.9M
Retained Earnings	-166.52M
Total Assets	237.69M
Working Capital	53.09M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -217K and capital expenditures -17.92M, giving a free cash flow of -18.14M.

Operating Cash Flow	-217K
Capital Expenditures	-17.92M
Free Cash Flow	-18.14M
FCF Per Share	-0.6

Full Cash Flow Statement

Margins

Gross margin is 32.63%, with operating and profit margins of -6.9% and 9.37%.

Gross Margin	32.63%
Operating Margin	-6.9%
Pretax Margin	7.42%
Profit Margin	9.37%
EBITDA Margin	27.76%
EBIT Margin	-6.9%
FCF Margin	-14.14%

Dividends & Yields

LFCR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	7.01%
FCF Yield	-10.59%

Dividend Details

Analyst Forecast

The average price target for LFCR is $8, which is 10.8% higher than the current price. The consensus rating is "Hold".

Price Target	$8
Price Target Difference	10.8%
Analyst Consensus	Hold
Analyst Count	4

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	3.96
Graham Upside	-45.15%

Scores

Altman Z-Score	0.04
Piotroski F-Score	4